Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology

NCT02562027 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02562027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
September 11, 2015
Completion date
November 1, 2020
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell-lung, non-small cell lung cancer, nonsmall cell lung cancer